Torre-Bouscoulet L

Language: Spanish
References: 6
Page: 221-223
PDF size: 151.79 Kb.

REFERENCES

1. Fowler AJ, Wan YI, Carenzo L, Haines RW. COVID-19 phenotypes and potential Hpharm of conventional treatments: how to prove the hypothesis. Am J Respir Crit Care Med. 2020;202(4):619-621. https://doi.org/10.1164/rccm.202004-1293le

2. Spriggs EA. John Hutchinson, the inventor of the spirometer–his north country background, life in London, and scientific achievements. Med Hist. 1977;21(4):357-364. https://doi.org/10.1017/s0025727300039004

3. Lee HM, Chung SJ, Lopez VA, Wong ND. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest. 2009;136(1):171-176. https://doi.org/10.1378/chest.08-1901

4. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012. https://doi.org/10.1056/nejmoa021322

5. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862-865. https://doi.org/10.1016/s0140-6736(81)92140-1

6. Torre-Bouscoulet L. Los retos de la medicina personalizada. Neumol Cir Torax. 2015;74(4):238-239.